| Autor: |
Shkurenko YV; Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia., Ibatov AD; Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia., Aliyeva UE; Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia., Trofimova SY; Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia., Einullayeva SE; Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia. |
| Jazyk: |
ruština |
| Zdroj: |
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova [Zh Nevrol Psikhiatr Im S S Korsakova] 2024; Vol. 124 (5. Vyp. 2), pp. 99-104. |
| DOI: |
10.17116/jnevro202412405299 |
| Abstrakt: |
Pregnancy is associated with a number of physiological changes in a woman's body, which in turn affect the quality and duration of sleep. According to research, insomnia and other sleep disorders are associated with a high risk of adverse pregnancy outcomes, as well as postpartum complications. Understanding the mechanisms of sleep disorders during pregnancy is necessary to form an integrated approach in the management of this group of patients. The appointment of medicinal and non-medicinal therapies, as well as general recommendations for lifestyle correction in order to treat sleep disorders, is focused on the safe and prolific effect of a particular drug on the mother and fetus. This review also examined the safety profile of commonly used groups of drugs for sleep disorders during pregnancy. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
